Assessment of Combined Praziquantel and Albendazole vs Albendazole Alone to Treat Active Parenchymal Neurocysticercosis

NCT06376396 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Neurocysticercosis

Interventions

DRUG: albendazole and praziquantel
DRUG: Albendazole

Sponsor

R-Evolution Worldwide S.r.l. Impresa Sociale

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]